SICA, Antonio
 Distribuzione geografica
Continente #
EU - Europa 5.198
NA - Nord America 4.666
AS - Asia 2.923
SA - Sud America 713
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 11
Totale 13.600
Nazione #
US - Stati Uniti d'America 4.562
IE - Irlanda 1.299
SG - Singapore 1.050
DE - Germania 903
SE - Svezia 762
IT - Italia 614
HK - Hong Kong 601
UA - Ucraina 563
BR - Brasile 558
CN - Cina 506
RU - Federazione Russa 346
VN - Vietnam 339
FI - Finlandia 301
GB - Regno Unito 105
KR - Corea 104
IN - India 92
EE - Estonia 85
AR - Argentina 68
ID - Indonesia 67
FR - Francia 62
CA - Canada 51
AT - Austria 42
TR - Turchia 41
MX - Messico 40
BD - Bangladesh 27
PL - Polonia 26
EC - Ecuador 25
ZA - Sudafrica 25
BE - Belgio 20
BJ - Benin 19
JP - Giappone 19
IQ - Iraq 16
NL - Olanda 16
CO - Colombia 15
ES - Italia 15
PY - Paraguay 14
EU - Europa 13
AU - Australia 11
TW - Taiwan 10
VE - Venezuela 10
CL - Cile 8
CZ - Repubblica Ceca 8
UY - Uruguay 8
EG - Egitto 7
LT - Lituania 7
MA - Marocco 7
PE - Perù 7
SA - Arabia Saudita 7
DK - Danimarca 6
KZ - Kazakistan 6
DZ - Algeria 5
UZ - Uzbekistan 5
IR - Iran 4
JM - Giamaica 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
JO - Giordania 3
NG - Nigeria 3
PH - Filippine 3
PT - Portogallo 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
CH - Svizzera 2
IL - Israele 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PK - Pakistan 2
PS - Palestinian Territory 2
RO - Romania 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 13.600
Città #
Dublin 1.296
Jacksonville 958
Hong Kong 593
Dearborn 465
Chandler 353
Singapore 271
Wilmington 235
Ashburn 226
Beijing 221
Piemonte 195
Bremen 177
Lawrence 176
Princeton 176
San Mateo 146
Los Angeles 124
Ho Chi Minh City 120
Moscow 120
Ann Arbor 118
Andover 113
Seoul 93
Buffalo 84
Düsseldorf 57
Hanoi 57
São Paulo 55
New York 47
Milan 46
Novara 45
Boardman 44
Munich 44
Woodbridge 35
Dong Ket 32
Santa Clara 32
Nuremberg 31
Redondo Beach 31
Hefei 30
Houston 30
Jakarta 29
Nanjing 27
Dallas 26
Frankfurt am Main 26
Norwalk 24
Philadelphia 23
Helsinki 22
Brussels 20
Brooklyn 19
Cotonou 19
Tokyo 19
Orem 18
Tianjin 18
Warsaw 18
Atlanta 17
Da Nang 17
Mexico City 17
Poplar 17
Chennai 16
Rio de Janeiro 16
Turin 16
Vienna 16
Denver 15
Haiphong 15
Toronto 15
Guangzhou 14
Kunming 14
Montreal 14
London 13
Boston 12
Fairfield 11
Johannesburg 11
Porto Alegre 11
Stockholm 10
Asunción 9
Biên Hòa 9
Brasília 9
Casalecchio Di Reno 9
Hải Dương 9
Kocaeli 9
Manaus 9
Ninh Bình 9
Baghdad 8
Falkenstein 8
Guayaquil 8
Manchester 8
New Delhi 8
Nichelino 8
Recife 8
Amsterdam 7
Cassano Magnago 7
Curitiba 7
Dhaka 7
Mumbai 7
Quito 7
San Francisco 7
Seattle 7
Thái Bình 7
Ankara 6
Belo Horizonte 6
Brno 6
Caxias do Sul 6
Changsha 6
Chatteris 6
Totale 7.698
Nome #
Cancer immunity and immunotherapy beyond COVID-19 194
Heme catabolism by tumor-associated macrophages controls metastasis formation 146
Macrophage polarization in pathology 145
Nicotinamide Phosphoribosyltransferase (NAMPT) acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 143
The p50 NF-κB subunit is a prognostic regulator of colorectal cancer-associated inflammation 142
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection 130
(0) Save to: more options FUNCTIONAL INTERACTION OF NF-KAPPA-B WITH INTERFERON-GAMMA GENOMIC DNA - IDENTIFICATION OF MULTIPLE NF-KAPPA-B AND NF-AT BINDING-SITES 128
RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis 122
Inflammaging and Osteoarthritis. 121
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors: novel modulators of antitumor immunity 116
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies 115
Functions of diverse myeloid cells in the tumor micro-environment 114
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 113
Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis 111
A distinct and unique transcriptional programme expressed by tumor-associated macrophages: defective NF-{kappa}B and enhanced IRF-3/STAT1 activation 106
Hypoxia-mediated regulation of macrophage functions in pathophysiology 104
The role of cytokines as communication signals between leukocytes and endothelial cells. 103
Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy 103
Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC. 103
Pro-tumor steering of cancer inflammation by p50 NF-κB enhances colorectal cancer progression 102
Cancer-related Inflammation 100
Macrophage polarization in tumour progression 100
A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). 100
The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance 100
Metabolic regulation of suppressive myeloid cells in cancer 99
Metabolic influence on the differentiation of suppressive myeloid cells in cancer. 99
Activation of nuclear factor of activated T cells in a cyclosporin A-resistant pathway. 98
AIRE modulates IFN- expression in T lymphocytes 97
Molecular and epigenetic basis of macrophage polarized activation 97
A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. 96
Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. 94
Myeloid-derived suppressor cells: Ductile targets in disease 94
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages 94
Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and non-hematopoietic cells 93
Bacterial lipopolisaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes 93
A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization 91
A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. 90
Endothelial cells express the interleukin-1 receptor type I. 90
Autocrine production of interleukin-10 (IL-10) mediates defective IL-12 production and NF-kappa B activation in tumor associated macrophages 90
Interaction of NF-kB and NFAT with the Interferon-gamma Promoter 90
ALTERATIONS IN NF-KAPPA-B/REL FAMILY PROTEINS IN SPLENIC T-CELLS FROM TUMOR-BEARING MICE AND REVERSAL FOLLOWING THERAPY 90
LPS-tolerant monocytes/macrophages express a distinct M2 functional profile 88
Hypoxia-mediated regulation of macrophage functions in pathophysiology. 88
IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member in Trypanosoma congolense infection-resistant C57BL/6 mice 87
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors are novel modulators of myeloid-derived suppressor cells 86
Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. 85
Inflammation and cancer: breast cancer as a prototype 84
Inflammation as target in cancer therapy 84
Oncolytic virotherapy: new weapon for breast cancer treatment 84
Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema. 83
Lipid metabolism and cancer immunotherapy: Immunosuppressive myeloid cells at the crossroad 82
Influence of innate immunity on cancer cell stemness 82
Immunometabolic interference between cancer and COVID-19 82
Targeting cancer cells and tumor microenvironment in preclinical and clinical models of Hodgkin lymphoma using the dual PI3Kd/G inhibitor RP6530 81
Cellular and molecular pathways linking inflammation and cancer 80
Expression of c-jun protooncogene in human myelomonocytic cells. 80
Interleukin-6 gene expression and production induced in human monocytes by membrane proteoglycans from Klebsiella pneumoniae. 79
IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. 79
MiR-146a and NF-kB1 regulate mast cell survival and T lymphocyte differentiation 79
The p50 subunit of NF-?B orchestrates dendritic cell lifespan and activation of adaptive immunity. 79
High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. 78
Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. 78
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene 78
convergent pathways of macrophage polarization: the role of B cells 78
Cancer related inflammation: the macrophage connection. 78
Nicotinamide Phosphorybosyltransferase (NAMPT) Inhibitors are Novel Modulator of Cancer-Related Inflammation 78
Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. 78
Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target. 78
Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. 77
NF-kappa B p50 regulates mast cell survival in part through upregulation of miR-146a 77
Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel. 75
Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. 75
Macrophage activation and polarization. 75
SPARC is a new myeloid-derived suppressor cell marker licensing suppressive activities 75
IDENTIFICATION OF NOVEL PROTEIN-BINDING SEQUENCES IN THE 1ST INTRON OF HUMAN INTERFERON-GAMMA-GENOMIC DNA 74
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. 74
Altered macrophage differentiation and immune dysfunctions during tumor development 74
Immunometabolic status of covid-19 cancer patients 74
NF-KAPPA-B AND A P120 INTERACT WITH THE IFN-GAMMA INTRONIC CREL BINDING-SITE C3 72
MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression. 72
Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs) 72
GADD45β loss ablates innate immunosuppression in cancer 72
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy. 72
Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. 70
Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation. 70
The p50 NF-kappa B subunit controls dendritic cell survival and immunogenicity 70
Mechanisms linking pathogens-associated inflammation and cancer 70
Propafenone and 5-hydroxypropafenone concentrations in the right atrium of patients undergoing heart surgery 70
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors 70
Suppressor of cytokine signaling (SOCS) 2 and 3: diametrically control macrophage polarisation 69
Macrophage activation and polarization as an adaptive component of innate immunity 69
Implications of metabolism-driven myeloid dysfunctions in cancer therapy 69
NEGATIVE TRANSCRIPTIONAL REGULATION OF THE INTERFERON-GAMMA (IFN-GAMMA) PROMOTOR BY GLUCOCORTICOIDS AND DOMINANT-NEGATIVE MUTANTS OF C-JUN 68
LPS-inducible nuclear factor in human monocytes that binds the negative regulatory element of the HIV LTR. 68
Defective expressione of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma 68
Mechanisms linking pathogens-associated inflammation and cancer 68
Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. 68
M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. 67
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards 67
Autocrine production of Interleukin-10 (IL-10) mediates defective IL-12 production and NF-kB activation in Tumor Associated Macrophages 67
Totale 8.930
Categoria #
all - tutte 73.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021793 0 0 0 0 0 35 186 17 187 90 210 68
2021/20221.276 36 5 271 200 47 20 129 16 88 19 180 265
2022/20232.775 199 114 121 103 331 244 42 173 1.321 8 77 42
2023/2024757 56 48 74 22 134 16 201 27 4 9 40 126
2024/20252.293 54 12 123 72 50 97 190 247 572 339 148 389
2025/20262.825 201 229 569 1.078 526 222 0 0 0 0 0 0
Totale 13.729